|Articles|August 2, 2016
OmniComm Signs Agreement with Research University
OmniComm Systems announced that it has signed an agreement with one of the top five medical research universities in the United States.
Advertisement
OmniComm Systems announced that it has signed an agreement with one of the top five medical research universities in the United States. The university plans to use OmniComm’s TrialMaster EDC and related services to conduct a series of clinical studies over a period of five years.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When AI Learns to Speak Every Language: An eCOA Migration Study
2
FDA Outlines New Superiority Standard for Future CAR-T Approvals
3
Accelerating Clinical Trial Timelines with AI
4
ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
